ARTICLE | Company News
FDA psychiatry product division director joins Allergan
February 5, 2019 8:33 PM UTC
Following a 12-year tenure as director of FDA’s Division of Psychiatry Products, Mitchell Mathis has joined Allergan plc (NYSE:AGN) as CMO for CNS products.
Mathis left FDA on Jan. 19 and joined Allergan later in the month. ...